Ahead Therapeutics SL
A tech-platform developing disease-modifying treatments to cure autoimmune diseases
Status
IP Type
Patent
Time
12 years
Countries
Coverage
Product patent. Claim 1: “A liposome encapsulating an autoantigen, wherein (i) the liposomes has a size comprised from 500 to 15000 nm; and (ii) the liposome membrane comprises phosphatidylserine (PS) in an amount comprised from 10 to 40% by weight with respect to the total membrane liposomal composition.”
Know more of this patent
Status
IP Type
PCT
Time
–
Countries
Coverage
Product patent. TOLEROGENIC COMPOSITION. Based on the innovative features discovered during the development of the Ahead’s Tech-Platform. It is based on the involvement of B Cells and scalable method of liposomes production process.
Know more of this patent
This information is confidential, do not share or copy.
You can visit their website or
Under evaluation at least till: 25th of June 2023
KEEP REVIEWING
